
Equillium, Inc.
EQNasdaqCIK 1746466HealthcareFiscal year ends Dec 31
Reports and events: 158 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-04-0916:05 ET | DEF 14A | Proxy statementPeriod 2021-05-26 | 0001564590-21-018327 |
| 2021-03-3016:52 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-016669 |
| 2021-03-2416:16 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-015103 |
| 2021-03-2416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-015101 |
| 2021-03-1508:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-013009 |
| 2021-03-0907:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-011597 |
| 2021-02-1617:21 ET | SC 13D | Ownership report, active investor | 0001104659-21-024389 |
| 2021-02-1215:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-005752 |
| 2021-02-0408:10 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-21-004194 |
| 2020-12-2108:06 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-322379 |
| 2020-12-0709:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-311281 |
| 2020-12-0409:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-310114 |
| 2020-11-3008:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-304969 |
| 2020-11-2508:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-303087 |
| 2020-11-1016:17 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-052979 |
| 2020-11-1016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-290153 |
| 2020-10-2917:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-281174 |
| 2020-09-2817:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-256711 |
| 2020-08-1416:50 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-220538 |
| 2020-08-1208:43 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-039503 |
| 2020-08-1208:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-217090 |
| 2020-08-1017:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-215058 |
| 2020-07-1406:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-192229 |
| 2020-07-1306:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-191424 |
| 2020-06-0108:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-156556 |
| 2020-05-2108:17 ET | 8-K | 5.07 Shareholder vote results | 0001564590-20-026454 |
| 2020-05-1316:16 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-025063 |
| 2020-05-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-025054 |
| 2020-04-2416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-20-018536 |
| 2020-04-0316:15 ET | DEF 14A | Proxy statementPeriod 2020-05-19 | 0001564590-20-015262 |
| 2020-03-3017:26 ET | S-1 | Registration statement | 0001564590-20-014306 |
| 2020-03-3016:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001564590-20-014185 |
| 2020-03-2616:16 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-013207 |
| 2020-03-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-013200 |
| 2019-12-1207:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-312050 |
| 2019-11-2716:08 ET | 8-K | 8.01 Other events | 0001193125-19-302509 |
| 2019-11-1216:17 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-042933 |
| 2019-11-1216:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-19-042913 |
| 2019-10-0116:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-19-036089 |
| 2019-08-1216:16 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001564590-19-031483 |
| 2019-08-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-19-031480 |
| 2019-06-1216:10 ET | 8-K | 5.07 Shareholder vote results | 0001564590-19-022336 |
| 2019-05-1316:21 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001564590-19-018839 |
| 2019-05-1316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-19-018833 |
| 2019-05-0118:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-130143 |
| 2019-04-2516:15 ET | DEF 14A | Proxy statementPeriod 2019-06-11 | 0001564590-19-013052 |
| 2019-03-2716:11 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001564590-19-009580 |
| 2019-03-2716:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-19-009579 |
| 2019-02-2616:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-051928 |
| 2019-02-2016:08 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-19-045346 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:43 ET. Listed shows no prices and gives no investment advice.